Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03803423 · ClinicalTrials.gov registry record · NA

Dissemination of the Donor Application: Utilizing Social Media to Identify Potential Live Organ Donors

A NA study of End Stage Renal Disease and End Stage Liver DIsease, sponsored by Johns Hopkins University.

Recruiting
Registry status
NA
Development phase
1,000
Enrollment target
6
Study locations

NCT03803423 is a NA study of End Stage Renal Disease and End Stage Liver DIsease that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 1,000 participants, above the 822-participant average among 86 other End Stage Renal Disease trials with a reported enrollment target (22% higher). The trial reports 6 study locations across 6 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03803423, a NA study of End Stage Renal Disease and End Stage Liver DIsease, is actively recruiting participants, sponsored by Johns Hopkins University.

RECRUITING
Registry status
NA
Development phase
1,000 participants
Enrollment target
6
Study locations

Study Summary

This study utilizes a web-based application to help patients on the organ transplant waitlist communicate patient's need for a living donor via social media and provide interested potential donors the opportunity to engage with the evaluation process.

Conditions Studied

End Stage Renal Disease End Stage Liver DIsease

Interventions

  • OTHER The Donor App

Study Locations (6)

California

  • Scripps Green Hospital - San Diego

Connecticut

  • Yale University - New Haven

Illinois

  • Rush University Medical Center - Chicago

Maine

  • Maine Medical Center - Portland

Maryland

  • The Johns Hopkins Hospital - Baltimore

Missouri

  • Washington University in St. Louis - St Louis

Trial Details

FieldValue
Enrollment Target 1,000 participants
Start Date 2017-11-27
Est. Completion 2026-11-27
Phase NA

Sponsor

Johns Hopkins University

1,448 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03803423

The ClinicalTrials.gov registry entry for NCT03803423 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 822-participant average among 86 other End Stage Renal Disease trials with a reported enrollment target (22% higher). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with End Stage Renal Disease appearing as the primary indexed condition, and to 1 intervention - of which The Donor App is the first listed.

NCT03803423 reports 6 study locations spanning 6 distinct geographic areas - top geographies include California, Connecticut, Illinois.

Frequently Asked Questions

What is clinical trial NCT03803423 about?

NCT03803423 is a clinical study titled "Dissemination of the Donor Application: Utilizing Social Media to Identify Potential Live Organ Donors". This study utilizes a web-based application to help patients on the organ transplant waitlist communicate patient's need for a living donor via social media and provide interested potential donors the opportunity to engage with the evaluation process.

What is the current status of trial NCT03803423?

This trial is currently recruiting. It is a NA study. The enrollment target is 1,000 participants. The study started on 2017-11-27. Estimated completion is 2026-11-27.

What conditions does trial NCT03803423 study?

This clinical trial studies the following conditions: End Stage Renal Disease, End Stage Liver DIsease.

What interventions are being tested in trial NCT03803423?

The interventions under investigation include: The Donor App (OTHER).

Who is sponsoring clinical trial NCT03803423?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03803423 being conducted?

This trial has 6 study locations across California, Connecticut, Illinois, Maine, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for End Stage Renal Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

End Stage Renal Disease

All registered trials for this condition

End Stage Liver DIsease

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.